Type C meningitis is a type of bacterial meningitis caused by the bacteria Neisseria meningitidis. Bacterial meningitis is a serious condition that requires prompt medical treatment with antibiotics.
Bacterial meningitis, often fatal if untreated, leads to inflammation around the brain and may cause severe complications ...
The FDA is expected to decide on treatments for Parkinson disease, PTSD and NF1-associated plexiform neurofibromas, in addition to 2 new vaccines.
M Levin, Department of Paediatrics, Faculty of Medicine, Imperial College of Science, Technology & Medicine, Norfolk Place, London W2 1PG, UK; m.levin{at}ic.ac.uk Neisseria meningitidis is remarkable ...
Adult patients with evidence of active thrombotic microangiopathy (TMA), including thrombocytopenia, evidence of hemolysis, and acute kidney injury * Vaccinations against Neisseria meningitidis, ...
In a statement, the FDA said Bkemv has been approved with the same boxed warning for increased risk of serious and life-threatening meningococcal infections caused by Neisseria meningitidis that ...
Neisseria Research Group, Molecular Microbiology, School of Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom In conclusion, the variety ...
Expert Rev Mol Diagn. 2012;12(7):731-754.
It launched Trelegy Ellipta, the countrys first single inhaler triple therapy (SITT) for the maintenance treatment of ... disease caused by Neisseria Meningitidis groups A, C, W-135 and Y ...